140 related articles for article (PubMed ID: 30235236)
1. TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.
Ding LY; Chu M; Jiao YS; Hao Q; Xiao P; Li HH; Guo Q; Wang YD
PLoS One; 2018; 13(9):e0203833. PubMed ID: 30235236
[TBL] [Abstract][Full Text] [Related]
2. [Effects of TFDP3 on regulating the autophagy and apoptosis of LNCaP cells].
Ren LF; Ma YY; Yue QH; Su MQ; Hao XK
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):347-9. PubMed ID: 22482402
[TBL] [Abstract][Full Text] [Related]
3. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.
Ma Y; Xin Y; Li R; Wang Z; Yue Q; Xiao F; Hao X
Gene; 2014 Mar; 537(2):253-9. PubMed ID: 24406621
[TBL] [Abstract][Full Text] [Related]
4. TFDP3 inhibits E2F1-induced, p53-mediated apoptosis.
Tian C; Lv D; Qiao H; Zhang J; Yin YH; Qian XP; Wang YP; Zhang Y; Chen WF
Biochem Biophys Res Commun; 2007 Sep; 361(1):20-5. PubMed ID: 17632080
[TBL] [Abstract][Full Text] [Related]
5. Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro.
Jiao Y; Ding L; Chu M; Wang T; Kang J; Zhao X; Li H; Chen X; Gao Z; Gao L; Wang Y
PLoS One; 2017; 12(8):e0182781. PubMed ID: 28797103
[TBL] [Abstract][Full Text] [Related]
6. TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer.
Yin K; Liu Y; Chu M; Wang Y
PLoS One; 2017; 12(1):e0170573. PubMed ID: 28114432
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
Sun HX; Xu Y; Yang XR; Wang WM; Bai H; Shi RY; Nayar SK; Devbhandari RP; He YZ; Zhu QF; Sun YF; Hu B; Khan M; Anders RA; Fan J
Hepatology; 2013 Mar; 57(3):1088-97. PubMed ID: 23212661
[TBL] [Abstract][Full Text] [Related]
8. Human TFDP3, a novel DP protein, inhibits DNA binding and transactivation by E2F.
Qiao H; Di Stefano L; Tian C; Li YY; Yin YH; Qian XP; Pang XW; Li Y; McNutt MA; Helin K; Zhang Y; Chen WF
J Biol Chem; 2007 Jan; 282(1):454-66. PubMed ID: 17062573
[TBL] [Abstract][Full Text] [Related]
9. TFDP3 as E2F Unique Partner, Has Crucial Roles in Cancer Cells and Testis.
Huang J; Wang Y; Liu J; Chu M; Wang Y
Front Oncol; 2021; 11():742462. PubMed ID: 34745961
[TBL] [Abstract][Full Text] [Related]
10. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
11. Taxol-induced unfolded protein response activation in breast cancer cells exposed to hypoxia: ATF4 activation regulates autophagy and inhibits apoptosis.
Notte A; Rebucci M; Fransolet M; Roegiers E; Genin M; Tellier C; Watillon K; Fattaccioli A; Arnould T; Michiels C
Int J Biochem Cell Biol; 2015 May; 62():1-14. PubMed ID: 25724736
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous cross-talk of E2F family members is crucially involved in growth modulatory effects of interferon-gamma and EGF.
Reimer D; Sadr S; Wiedemair A; Concin N; Hofstetter G; Marth C; Zeimet AG
Cancer Biol Ther; 2006 Jul; 5(7):771-6. PubMed ID: 16721044
[TBL] [Abstract][Full Text] [Related]
13. Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes.
Komori H; Goto Y; Kurayoshi K; Ozono E; Iwanaga R; Bradford AP; Araki K; Ohtani K
Sci Rep; 2018 May; 8(1):8438. PubMed ID: 29855511
[TBL] [Abstract][Full Text] [Related]
14. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B
J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
Zheng H; Wang JJ; Yang XR; Yu YL
World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
[TBL] [Abstract][Full Text] [Related]
16. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.
Hamurcu Z; Delibaşı N; Geçene S; Şener EF; Dönmez-Altuntaş H; Özkul Y; Canatan H; Ozpolat B
J Cancer Res Clin Oncol; 2018 Mar; 144(3):415-430. PubMed ID: 29288363
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal protein L5 (RPL5)/ E2F transcription factor 1 (E2F1) signaling suppresses breast cancer progression via regulating endoplasmic reticulum stress and autophagy.
Ma X; Li Y; Zhao B
Bioengineered; 2022 Apr; 13(4):8076-8086. PubMed ID: 35293275
[TBL] [Abstract][Full Text] [Related]
18. E2F-1 lacking the transcriptional activity domain induces autophagy.
Garcia-Garcia A; Rodriguez-Rocha H; Tseng MT; Montes de Oca-Luna R; Zhou HS; McMasters KM; Gomez-Gutierrez JG
Cancer Biol Ther; 2012 Sep; 13(11):1091-101. PubMed ID: 22825328
[TBL] [Abstract][Full Text] [Related]
19. IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.
Fan Y; Wang X; Li Y
Int J Med Sci; 2021; 18(14):3342-3352. PubMed ID: 34400904
[No Abstract] [Full Text] [Related]
20. Regulation of BRCA1 expression by the Rb-E2F pathway.
Wang A; Schneider-Broussard R; Kumar AP; MacLeod MC; Johnson DG
J Biol Chem; 2000 Feb; 275(6):4532-6. PubMed ID: 10660629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
